LifeCell International Unlisted Share
LifeCell International Pvt Ltd
INE313W01013
Listing Status: DRHP Not Filed
About LifeCell International Unlisted Share
Overview of LifeCell International Unlisted Share
Snapshot
LifeCell, founded in 2004, focuses on stem cell and tissue storage, genetic screening, and cell-based therapeutics. By integrating cellular sciences with traditional knowledge, the company offers innovative healthcare solutions and continues to develop products that address both current and future medical needs.
Product Portfolio
- Health Bank: Offers long-term stem cell storage and preservation solutions, including BabyCord 75 Years (₹63,551) for lifetime storage and SpermVault - One Baby (₹11,864) for sperm banking.
- Health Check: Provides comprehensive health screening options, such as Ayushman Maximum (₹2,399) for vital organs and FertiScore (₹7,599) for reproductive health.
- Health Clinic: Features advanced treatments and care products like AmnioPlast THICK™ for ocular wounds and MesoCel for Covid-19 cell-based therapy.
Merger
- In 2022, MFine merged with LifeCell’s diagnostics division to form a new entity, LifeWell. MFine faced financial issues and significant layoffs, having previously raised $97 Mn.
- Investment Details: LifeWell secured $80 Mn in investment from OrbiMed.
- Previous Financials: MFine was valued at $450 Mn-$500 Mn before the merger. LifeCell’s diagnostics and MFine together had over 6 Mn users, with plans to reach 50 Mn in four years.
Initiatives
Flexible Financing for Stem Cell Banking
- Partnership: Collaborating with Bajaj Finserv and LiquiLoans.
- EMI Plans: Zero-interest options with down payments as low as INR 1.
- Buy Now Pay Later: Pay only three out of six EMIs, starting from the fourth month, with processing fees in the first three months.
- Accessibility: Aims to make stem cell banking more affordable and convenient.
- Hybrid Banking Model: Adheres to Indian Paediatric Association’s recommendations with a large stem cell repository and advanced genomic profiling for safety.
Certifications
- Association for the Advancement of Blood & Biotherapies (AABB)
- Information Security Management Certification
- ICCBBA ISBT 128 Standard Compliance
- USFDA Registration and more
Management
Abhaya Kumar Jain | Chairman
- Experience: Entrepreneur with ventures in healthcare, animation, manufacturing, BPO, women’s education, and cremation services, managing multiple enterprises simultaneously.
Mayur Abhaya Jain | Managing Director
- Experience: Biotechnology expert with a focus on scientific innovation, pharmaceuticals, and Six Sigma, driving high-quality standards and disruptive market offerings at LifeCell.
Sumanth Sarangapani | CEO
- Education: Certified Lead Auditor QMS, ISMS NABL lead assessor, and trained in Leadership & High-Performance Organizations by IIM.
- Experience: 14 years at LifeCell managing Supply Chain, Customer Service, and Business Process Automation; skilled in delivering new products and services efficiently.
Insights of LifeCell International Unlisted Share
Financial Snapshot
All Values are in INR Cr.
Particulars |
FY23 |
FY22 |
Revenue |
170.75 |
137.16 |
EBITDA |
14.11 |
-22.62 |
PAT |
107.31 |
-11.56 |
PAT Margin |
37.15% |
-108.43% |
Key Takeaways:
- Revenue has increased by almost 25% in FY23 indicative of positive prospects.
- EBITDA is positive in FY23 after a loss making run.
- PAT has increased exponentially over the financial year, owing to a large contribution by exceptional items.
Peer Comparison
All values are in INR Cr for FY23.
Particulars |
Lifecell |
KMC Speciality Hospitals Ltd. |
Revenue |
170.75 |
158.89 |
PAT |
107.31 |
26.69 |
PAT Margin |
37.15% |
16.8% |
Current Market Price (02/09/24) |
550 |
88.56 |
MCAP |
1009 |
1426 |
P/E |
9.40 |
49.75 |
P/S |
5.91 |
8.97 |
P/B |
4.84 |
10.06 |
Funding
- Capital Raised: ₹255 crore from OrbiMed (₹225 crore) and existing founders (₹30 crore).
- Usage: To support growth, expansion into new categories, and storage divisions.
- Advisors: Ernst & Young LLP (investment banking) and LKS (legal).
- Board Update: Sunny Sharma of OrbiMed Asia to join LifeCell’s Board.
- Growth: Aims for high double-digit revenue growth, with past revenue at ₹234 crore and increased focus on biological division.
LifeCell has raised a total funding of $61.2 million across five rounds, signifying its substantial backing from investors over the years
Financial Charts of LifeCell International Unlisted Share
Balance Sheet of LifeCell International Unlisted Share
Profit and Loss of LifeCell International Unlisted Share
Ancillary of LifeCell International Unlisted Share
Ratio Analysis
Peers
Industry Benchmarking
Segment Revenue
Subsidaries
Security Allotment
Corporate Governance
Team Management Details
FAQs of LifeCell International Unlisted Share
-
How to buy LifeCell International Pvt Ltd?
Below are three ways through which you can purchase LifeCell International Pvt Ltd:
- We at Altius Investech have many actively traded scripts and are market makers of unlisted shares. To check out all the unlisted shares traded. (Click on link). To submit a request to buy LifeCell International Pvt Ltd, please click on the trade button at the top of this page
- Additionally, you can download our app from your play store or app store, register on our application, and engage in active trading there.
Download the Altius App here https://onelink.to/hf4m72 - You can also reach out to us at : +91 8240614850 / +91 8240861716
-
How to sell LifeCell International Pvt Ltd?
Below are three ways through which you can sell LifeCell International Pvt Ltd:
- We at Altius Investech have many actively traded scripts and are market makers of unlisted shares. To check out all the unlisted shares traded. (Click on link). To submit a request to sell LifeCell International Pvt Ltd, please click on the trade button at the top of this page
- Additionally, you can download our app from your play store or app store, register on our application, and engage in active trading there.
Download the Altius App here https://onelink.to/hf4m72 - You can also reach out to us at : +91 8240614850 / +91 8240861716
-
What is the price of LifeCell International Pvt Ltd?
We provide a two way quote on all the shares we deal in. Your buy price for LifeCell International Pvt Ltd is ₹585 and your sell price for LifeCell International Pvt Ltd is ₹400. The price is based on our estimates and market conditions.
-
What is the lock-in period of LifeCell International Pvt Ltd?
The lock-in period for LifeCell International Pvt Ltd varies depending on the category of investors:
- For retail Investors, HNIs, or Body Corporates, the lock-in period is 6 months from the date of the listing of LifeCell International Pvt Ltd
- For Venture Capital Funds or Foreign Venture Capital Investors, there is a lock-in period of 6 months from the date of acquisition of LifeCell International Pvt Ltd
- For AIF-II (Alternative Investment Funds - Category II), there is no lock-in period
August 2021 saw the introduction of this regulation by SEBI. The purpose of the regulation change, which lowered the lock-in period from a year to six months, was to incentivize additional investments in firms getting ready for initial public offerings, or IPOs. Since its introduction, a number of Portfolio Management Services (PMS) have advised their clients to purchase Pre-IPO shares in order to take advantage of the advantages associated with early-stage investments. This reduction in the lock-in period is considered as a significant step forward.
-
How is the LifeCell International Pvt Ltd price calculated?
Fundamental & Comparative valuation models and the forces of demand and supply in the market for unlisted shares dictate the price. These prices are based on our estimates and transaction history of LifeCell International Pvt Ltd. The price is also determined from the most recent funding round for LifeCell International Pvt Ltd. This provides us with a benchmark valuation, offering a clear indication of the company's current market value as perceived by investors and industry experts.
-
What are the lot sizes of LifeCell International Pvt Ltd?
We can generally arrange lot sizes starting with an investment of INR 20,000. To confirm the lot sizes of LifeCell International Pvt Ltd with us kindly click here.
-
What are the financials of LifeCell International Pvt Ltd?
The financials of LifeCell International Pvt Ltd which includes the P/L of LifeCell International Pvt Ltd and the Balance Sheet of LifeCell International Pvt Ltd is in the financials section (Click on link).
-
Where can I find the annual report of LifeCell International Pvt Ltd?
The annual report of LifeCell International Pvt Ltd is available in the annual report section (Click on link).
-
Is buying LifeCell International Pvt Ltd legal in India?
Yes, buying and selling unlisted shares in India is indeed 100% legal. This activity is regulated and governed under the guidelines provided by the Securities and Exchange Board of India (SEBI). Investors and traders must adhere to these regulations and guidelines to ensure compliance with legal and financial standards. It's important for participants in the unlisted share market to be aware of and understand these regulations to engage in transactions legally and securely.
-
Short-term Capital Gain taxes to be paid on LifeCell International Pvt Ltd?
When you sell unlisted shares within a period of two years from the date of acquisition, any profit earned from the sale is classified as Short-term Capital Gain (STCG). This gain is then added to your total income for that financial year. The tax on this short-term capital gain is calculated based on your applicable individual income tax slab rates. Therefore, the rate at which you will pay tax on the STCG from unlisted shares depends on your total income, including this gain, and the tax slab it falls under as per the prevailing income tax laws in India. It's important for investors to consider these tax implications when engaging in transactions involving unlisted shares.
-
Long-term Capital Gain taxes to be paid on LifeCell International Pvt Ltd and how are They Taxed?
Long-term Capital Gains (LTCG) on unlisted shares in India refer to the profits earned from the sale of unlisted shares that have been held for more than two years. The key aspects of LTCG on unlisted shares include:
- Tax Rate: LTCG on unlisted shares is taxed at a rate of 20%.
- Indexation Benefit: This is a significant advantage for investors. Indexation allows for adjusting the purchase price of the shares for inflation, which can reduce the taxable gain.
- Importance for Investors: Understanding LTCG is crucial, especially for High Net-worth Individuals (HNIs) and retail investors, as it impacts their investment strategy and tax planning. Knowing these details helps in making informed investment decisions.
- Calculation: LTCG is calculated by subtracting the indexed cost of acquisition (the purchase price adjusted for inflation) from the sale price of the shares. The profit thus calculated is subject to a 20% tax.
- Applicability: LTCG tax is applicable to profits from the sale of unlisted shares held for more than two years.
- Relevance: This tax is particularly relevant to investors in the unlisted share market, including those considering selling their holdings after a period of more than two years.
-
Applicability of Taxes on LifeCell International Pvt Ltd once it is listed?
When shares initially bought in the unlisted market become listed, the taxation rules change significantly if these shares are sold through a stock exchange. Here's what investors need to know:
Transition to Listed Market Tax Rates: Once unlisted shares are listed on the stock exchange and subsequently sold, the tax rates applicable to listed securities come into effect. This shift means that the favourable tax treatments for listed shares, as per the prevailing tax laws, will apply.
Taxation Based on Holding Period: The crucial factor in determining the type of capital gains tax (Long-term or Short-term) is the holding period of the shares. Importantly, this period is calculated from the original purchase date when the shares were unlisted.
Long-term vs. Short-term Capital Gains: If the shares are sold after being held for more than one year from the date of purchase (including the period when they were unlisted), they are subject to Long-term Capital Gains (LTCG) tax.
Conversely, if sold within one-year, Short-term Capital Gains (STCG) tax rates apply.
Significance for Investors: This information is vital for investors in the unlisted market, as it impacts their tax planning and decision-making process. Understanding these nuances ensures that investors can strategically plan the sale of their shares post-listing to optimize tax implications.
Advice for Investors: It's advisable for investors to keep a record of their purchase dates and monitor the listing dates closely. Additionally, staying updated with the latest tax regulations or consulting with a financial advisor is recommended for accurate tax calculations and compliance. -
How does Altius Investech source LifeCell International Pvt Ltd?
At Altius Investech, our approach to sourcing Boat Unlisted Share (Imagine Marketing) involves a strategic and direct method. Primarily, we acquire these shares from the below key groups:
Employees of the Company: Employee stock option plans (ESOPs) or other compensation packages frequently include shares for firm employees. For a various reasons, such as including portfolio diversification or financial considerations, some of these employees may eventually choose to sell their shares. We engage with these employees, providing them a platform to sell their shares.
Initial Investors: These are the angel or early-stage investors who provided capital to the business in its early stages. These original investors may look to sell all or part of their ownership position in the company as it develops and flourishes. This might be done for various reasons such as in order to maximise their investment, reallocate resources, or make other calculated financial decisions.
Funding rounds and VC funds: Altius Investech sources the shares from private placement rounds in which private companies seek to obtain capital from the market. Through our platform, venture capital funds can liquidate their shares and we receive the inventory from them when they decide to sell a portion of their ownership through block trades.
By establishing connections with these groups, Altius Investech guarantees our clients a steady and dependable supply of Boat Unlisted Share (Imagine Marketing). This process not only makes it easier for employees and initial investors in liquidating their assets, but it also gives our clients access to shares that aren't often found on the open market. Our platform effectively facilitates a win-win situation for both buyers and sellers. -
How to trust Altius Investech before buying LifeCell International Pvt Ltd from its platform?
Altius Investech stands at being India's fastest growing and leading marketplace for buying and selling unlisted shares. We believe in enabling access to alternative sources of investments at lower entry barriers to private equity investments.
With more than 25 years of experience, Altius Investech has carved a niche in the financial market by serving more than 8000 clients. The incredible journey is further highlighted by the vast number of transactions that Altius Investech has facilitated transactions that have already exceeded 300 crores.
For investors Altius Investech curates investment opportunities in companies at reasonable valuations which are on the verge of an IPO leading to massive value unlocking. Investments are backed by thorough research and sound investment thesis, with a time bound exit plan.
For ESOP Shareholder and existing Investors, we assist them to liquidate their shares even if they are not publicly traded by creating a platform where we find the right buyers and sellers for the best prices.
Altius Investech have been featured in top media news outlets like Economic Times, Financial Express, Money control. Check out about us on these - leading publications (Click on link) Our journey over these years has not just been about numbers; it's been about building trust and reliability.
We at Altius Investech are dedicated to upholding the greatest levels of ethics and transparency, making sure that your investment experience is not only profitable but also safe and reliable.
Press of LifeCell International Unlisted Share
Featured Blogs of LifeCell International Unlisted Share
Annual Report of LifeCell International Unlisted Share
Company Information of LifeCell International Unlisted Share
Featured Companies
Stay Connected.
Registered Address
73A, GC Avenue, Kolkata -13Corporate Address
Y-19, 90 DEGREES Magnus, EP Block,Sec V, Kolkata 700091Chennai Office
19/10, Guru Vappa Chetty Street, Chintadripet, Chennai - 600002
Dubai Office
2701, Executive Tower G, Business Bay, Dubai, UAE
Andhra Pradesh & Telangana Office
54-19-25/1, Flat no.101, Sai Residency, Nelson Mandela Park Road, LIC Colony, Vijayawada (Urban), Andhra Pradesh - 520008Altius Investech